Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II pilot study of cysteamine bitartrate plus epigallocatechin gallate in cystic fibrosis
2013-001258-82Phase 2Completed
- Sponsor
- European Institute for Cystic Fibrosis Research
- Start
- Jul 2013
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of cysteamine and epigallocatechin gallate in cystic fibrosis (CF), sponsored by European Institute for Cystic Fibrosis Research. Primary endpoint: Sweat chloride reduction. Started Jul 2013; status: completed.
02
Drugs
cysteamineepigallocatechin gallate
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2013-001258-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001258-82.